Pre-Ordering for Under 5 Vaccines Now Open in Philavax
Pfizer-BioNTech and Moderna are conducting clinical trials and data collection for COVID-19 vaccines for children ages 6 months through 4 years and 6 months through 5 years, respectively. Both companies have submitted data for review to the FDA. The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) is tentatively scheduled to meet on June 15, 2022, to discuss both the Pfizer-BioNTech vaccine for children aged 6m–4 years and the Moderna vaccine for children aged 6m–5 years. The CDC’s Advisory Committee on Immunization Practices (ACIP) is anticipated to meet within several days of VRBPAC, to make official recommendations.
In anticipation of the vaccine rollout, pre-ordering for both of these formulations (Moderna and Pfizer) is now open in Philavax. Between now and Wednesday, the 8th, at 5pm, COVID-19 vaccine providers can place a pre-order for the under 5 vaccines. Submission of both a temperature log and a reconciliation is also required to process provider orders. While both formulations (Moderna and Pfizer) will be available for ordering in the system, providers are strongly encouraged to order and stick with one under 5 vaccine product/manufacturer in order to prevent administration and handling errors.
Shipment of Pfizer-BioNTech COVID-19 vaccine for ages 6m–4 years and/or Moderna COVID-19 vaccine for ages 6m–5 years is planned to begin once FDA issues the EUA(s), tentatively arriving between the 23rd-29th. However, vaccine administration can only begin following the CDC/ACIP recommendation(s).
Here’s what we know about both vaccines so far (which could change pending FDA review):